Related Experiment Video
Updated: Feb 3, 2026

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Bone marrow stem cells-derived exosomes extracted from osteoporosis patients inhibit osteogenesis via
1Department of Orthopedics, Guangzhou University of Chinese Medicine, Guangzhou, China. Shuangyugang@163.com.
Objective:
To explore whether bone marrow stem cells (MSCs)-derived exosomes extracted from osteoporosis patients could inhibit osteogenesis via microRNA-21/SMAD7.
Patients And Methods:
MSCs from osteoporosis patients were isolated and cultured. MSCs morphology was observed, and the specific surface antigens were identified by flow cytometry. The osteogenic ability of MSCs was detected by alizarin red staining and oil red staining. Exosomes were collected from MSCs suspension by ultracentrifugation, and microRNA-21 expression in MSCs derived-exosomes was detected. Moreover, protein and mRNA levels of ALP, Bglap, and Runx2 in MSCs treated with different sources of MSCs-derived exosomes were detected by qRT-PCR (quantitative real-time polymerase chain reaction) and Western blot, respectively. ALP activity in MSCs was accessed by a relative commercial kit. Furthermore, binding sites of microRNA-21 and SMAD7 were predicted by Targetscan, miRWalk, and miRDB, and were further verified by luciferase reporter gene assay. SMAD7 expression in MSCs derived-exosomes was also detected.
Results:
MSCs extracted from healthy adults, and osteoporosis patients were in adherent growth and exhibited elongated morphology, which could differentiate into osteoblasts and lipoblasts after different inductions. MicroRNA-21 expression in MSCs-derived exosomes extracted from osteoporosis patients was remarkably higher than those extracted from healthy adults. Decreased Runx2 expression and ALP activity were found after treatment of MSCs-derived exosomes extracted from osteoporosis patients. SMAD7 was confirmed to bind to microRNA-21 and was downregulated in osteoporosis patients in comparison with healthy adults. Overexpression of SMAD7 resulted in downregulated ALP, Bglap, and Runx2.
Conclusions:
MicroRNA-21 inhibits osteogenesis through regulating MSCs-derived exosomes extracted from osteoporosis patients via targeting SMAD7.
Insights
MicroRNA-21 in exosomes from osteoporosis patients
Area of Science:
- Biomedical research
- Stem cell biology
- Molecular biology
Background:
- Osteoporosis is a bone disease characterized by low bone mass and microarchitectural deterioration.
- Mesenchymal stem cells (MSCs) play a crucial role in bone formation and regeneration.
- Exosomes are small vesicles involved in intercellular communication, carrying various biomolecules.
Purpose of the Study:
- To investigate the role of microRNA-21 (miR-21) within exosomes derived from mesenchymal stem cells (MSCs) of osteoporosis patients.
- To determine if these exosomes inhibit osteogenesis by targeting the SMAD7 gene.
Main Methods:
- Isolation and culture of MSCs from healthy donors and osteoporosis patients.
- Characterization of MSCs and their osteogenic potential.
- Isolation and characterization of exosomes using ultracentrifugation.
- Quantification of miR-21 and SMAD7 expression in MSCs and exosomes.
- Assessment of osteogenic markers (Runx2, ALP, Bglap) and ALP activity.
- Luciferase reporter gene assay to confirm miR-21 and SMAD7 interaction.
Main Results:
- MSCs from osteoporosis patients exhibited normal morphology and differentiation potential.
- Exosomes from osteoporosis patients' MSCs showed significantly higher miR-21 levels compared to healthy controls.
- Treatment with exosomes from osteoporosis patients' MSCs reduced Runx2 expression and ALP activity in recipient MSCs.
- SMAD7 was validated as a direct target of miR-21 and was downregulated in exosomes from osteoporosis patients.
- Overexpression of SMAD7 led to decreased expression of osteogenic markers (ALP, Bglap, Runx2).
Conclusions:
- MicroRNA-21 within exosomes derived from osteoporosis patients' MSCs inhibits osteogenesis.
- This inhibition occurs through the downregulation of SMAD7, a key regulator of bone formation.
More Related Videos
10:47Isolation and Cellular Phenotyping of Mesenchymal Stem Cells Derived from Synovial Fluid and Bone Marrow of Minipigs
Published on: July 2, 2016
11:37Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018
Related Concept Videos
MicroRNAs
MicroRNAs
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Induced Pluripotent Stem Cells
Feedback Inhibition
Adult Stem Cells